{"protocolSection":{"identificationModule":{"nctId":"NCT01554332","orgStudyIdInfo":{"id":"C-11-13"},"organization":{"fullName":"Abbott Medical Devices","class":"INDUSTRY"},"briefTitle":"Motor Cortex Stimulation for Chronic Neuropathic Pain","officialTitle":"A Clinical Evaluation for the Management of Patients With Chronic Neuropathic Pain With Cortical Stimulation"},"statusModule":{"statusVerifiedDate":"2020-06","overallStatus":"UNKNOWN","lastKnownStatus":"ACTIVE_NOT_RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2012-10"},"primaryCompletionDateStruct":{"date":"2020-12-31","type":"ESTIMATED"},"completionDateStruct":{"date":"2020-12-31","type":"ESTIMATED"},"studyFirstSubmitDate":"2012-01-13","studyFirstSubmitQcDate":"2012-03-12","studyFirstPostDateStruct":{"date":"2012-03-14","type":"ESTIMATED"},"lastUpdateSubmitDate":"2020-06-11","lastUpdatePostDateStruct":{"date":"2020-06-12","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Abbott Medical Devices","class":"INDUSTRY"}},"oversightModule":{"oversightHasDmc":false},"descriptionModule":{"briefSummary":"The purpose of this study is to evaluate the efficacy of cortical stimulation (CS) as an adjunctive treatment for chronic neuropathic pain.","detailedDescription":"Prospective, controlled, double blind, randomized, crossover study with endpoint evaluations at the end of each 3-month treatment period.\n\nAn interim analysis will be conducted by a blinded committee when approximately half of the patients have finished the study."},"conditionsModule":{"conditions":["Neuropathic Pain","Facial Pain","Post-stroke Pain","Brachial Plexus Avulsion","Phantom Limb Pain of the Upper Extremities"],"keywords":["Motor Cortex Stimulation","Neuropathic pain"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"CROSSOVER","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"TRIPLE","whoMasked":["PARTICIPANT","INVESTIGATOR","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":38,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Active stimulation","type":"ACTIVE_COMPARATOR","interventionNames":["Device: Motor Cortex Stimulation using SJM EonC Stimulator"]},{"label":"Sham stimulation","type":"SHAM_COMPARATOR","interventionNames":["Device: Motor Cortex Stimulation using SJM EonC Stimulator"]}],"interventions":[{"type":"DEVICE","name":"Motor Cortex Stimulation using SJM EonC Stimulator","description":"Patients will be randomized to receive either active stimulation the first 3 months followed by a one-month washout, followed by Sham Stimulation the next 3 months, vs. the reverse order of treatment, followed by single blind stimulation, and an open label phase.","armGroupLabels":["Active stimulation","Sham stimulation"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Visual Analog Scale (VAS)","description":"The primary analysis of effectiveness is based on the mean differences in changes from the period-specific baseline in VAS scores when patients are receiving 3 month of active vs. 3 months of sham stimulation on a double-blinded fashion.","timeFrame":"Approximately 7 months"}],"secondaryOutcomes":[{"measure":"Visual Analog Scale, responder","description":"defined as a ≥30% or 2 points reduction from baseline in VAS scores","timeFrame":"Participants will be followed for approximatley 18 months"},{"measure":"Neuropathic Pain Symptom Inventory (NPSI)","timeFrame":"Participants will be followed for approximatley 18 months"},{"measure":"Brief Pain Inventory (BPI)","timeFrame":"Participants will be followed for approximatley 18 months"},{"measure":"Short Form of the McGill Pain Questionnaire(SF-MPQ)","timeFrame":"Participants will be followed for approximatley 18 months"},{"measure":"Sickness Impact Profile (SIP)","timeFrame":"Participants will be followed for approximatley 18 months"},{"measure":"Medication Quantification Scale (MQS)","timeFrame":"Participants will be followed for approximatley 18 months"},{"measure":"SF-36 Health Survey and safety","timeFrame":"Participants will be followed for approximatley 18 months"},{"measure":"Pain Catastrophizing Scale (PCS)","timeFrame":"Participants will be followed for approximatley 18 months"},{"measure":"Global Impression of Change (patient and evaluator's version)","timeFrame":"Participants will be followed for approximatley 18 months"},{"measure":"Device related Adverse Events","timeFrame":"Participants will be followed for approximatley 18 months"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Men and women (non-pregnant) age 21-70 years;\n* Able to give informed consent in accordance with institutional policies;\n* Diagnosis of chronic neuropathic pain according to the DN4 Neuropathic Pain Diagnosis scale (score ≥ 4).\n* Documented pain for at least 12 months;\n* Documented previous or current treatment for neuropathic pain with medications from at least two of the following groups at adequate doses: antidepressants, anticonvulsants, and/or gabapentinoids;\n* VAS scores of at least 6 during baselines #1 and 2.\n* Documented clinical diagnosis of neuropathic pain associated with one of the following conditions: facial pain, post-stroke pain, brachial plexus avulsion, or phantom limb pain of the upper extremities.\n* In the group with post-stroke pain, only patients with predominant face and upper extremity pain will be included. This will be defined as a difference of ≥ 30% or ≥ 2 points in VAS scores between these regions and lower extremity (in patients who also have pain in the leg).\n* No change in current neuropathic pain medication regimen for at least 4 weeks prior to study enrollment.\n* Able to comply with all testing and follow-up requirements as defined by the study protocol.\n* Must be determined medically stable by surgeon to undergo cortical stimulation surgical procedure.\n\nExclusion Criteria:\n\n* Alcohol, medication, or illegal substance dependence or abuse within last 12 months;\n* Trigeminal neuralgia or atypical facial pain.\n* Post-stroke pain predominantly in the lower extremity.\n* Advanced cardiovascular disease which renders anesthesia and surgery as unsafe as determined by neurosurgeon;\n* Clinically relevant abnormality (e.g. tumor) on study MRI;\n* Has cardiac pacemaker/defibrillator or other implanted active stimulator;\n* Has a medical condition requiring a repetitive MRI body scan;\n* Requires chemotherapy for the treatment of malignancy or requiring chronic oral or intravenous, immunosuppressive, or steroid therapy;\n* Is unable to comply with study visit schedule and timeline;\n* Past ablative or relevant intracranial surgery;\n* A female lactating or of child bearing potential, with a positive pregnancy test or not using adequate contraception;\n* Other medical conditions likely to require hospitalization within the next year.","healthyVolunteers":false,"sex":"ALL","minimumAge":"21 Years","maximumAge":"70 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Edward Karst","affiliation":"Abbott Neuromodulation","role":"STUDY_DIRECTOR"}],"locations":[{"facility":"University of São Paulo - Hospital das Clínicas","city":"São Paulo","country":"Brazil","geoPoint":{"lat":-23.5475,"lon":-46.63611}}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000009437","term":"Neuralgia"},{"id":"D000010591","term":"Phantom Limb"},{"id":"D000005157","term":"Facial Pain"}],"ancestors":[{"id":"D000010523","term":"Peripheral Nervous System Diseases"},{"id":"D000009468","term":"Neuromuscular Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000010146","term":"Pain"},{"id":"D000009461","term":"Neurologic Manifestations"},{"id":"D000010468","term":"Perceptual Disorders"},{"id":"D000019954","term":"Neurobehavioral Manifestations"},{"id":"D000010149","term":"Pain, Postoperative"},{"id":"D000011183","term":"Postoperative Complications"},{"id":"D000010335","term":"Pathologic Processes"}],"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M12071","name":"Neuralgia","asFound":"Neuropathic Pain","relevance":"HIGH"},{"id":"M13188","name":"Phantom Limb","asFound":"Phantom Limb","relevance":"HIGH"},{"id":"M20779","name":"Facies","relevance":"LOW"},{"id":"M12756","name":"Pain","relevance":"LOW"},{"id":"M7990","name":"Facial Pain","asFound":"Facial Pain","relevance":"HIGH"},{"id":"M833","name":"Fractures, Avulsion","relevance":"LOW"},{"id":"M13122","name":"Peripheral Nervous System Diseases","relevance":"LOW"},{"id":"M12101","name":"Neuromuscular Diseases","relevance":"LOW"},{"id":"M12094","name":"Neurologic Manifestations","relevance":"LOW"},{"id":"M13069","name":"Perceptual Disorders","relevance":"LOW"},{"id":"M21516","name":"Neurobehavioral Manifestations","relevance":"LOW"},{"id":"M12759","name":"Pain, Postoperative","relevance":"LOW"},{"id":"M13755","name":"Postoperative Complications","relevance":"LOW"},{"id":"T1303","name":"Chronic Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"BXM","name":"Behaviors and Mental Disorders"},{"abbrev":"BC26","name":"Wounds and Injuries"},{"abbrev":"Rare","name":"Rare Diseases"}]}},"hasResults":false}